story of the week
Effect of Evacetrapib on Cholesterol Efflux Capacity and Pre-Beta-1 HDL Levels
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American College of Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib
J Am Coll Cardiol 2015 Nov 17;66(20)2201-2210, SJ Nicholls, G Ruotolo, HB Brewer, JP Kane, MD Wang, KA Krueger, SJ Adelman, SE Nissen, DJ RaderFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.